Literature DB >> 19635798

p110 CUX1 homeodomain protein stimulates cell migration and invasion in part through a regulatory cascade culminating in the repression of E-cadherin and occludin.

Valerie Kedinger1, Laurent Sansregret, Ryoko Harada, Charles Vadnais, Chantal Cadieux, Kelly Fathers, Morag Park, Alain Nepveu.   

Abstract

In this study, we investigated the mechanism by which the CUX1 transcription factor can stimulate cell migration and invasion. The full-length p200 CUX1 had a weaker effect than the proteolytically processed p110 isoform; moreover, treatments that affect processing similarly impacted cell migration. We conclude that the stimulatory effect of p200 CUX1 is mediated in part, if not entirely, through the generation of p110 CUX1. We established a list of putative transcriptional targets with functions related to cell motility, and we then identified those targets whose expression was directly regulated by CUX1 in a cell line whose migratory potential was strongly stimulated by CUX1. We identified 18 genes whose expression was directly modulated by p110 CUX1, and its binding to all target promoters was validated in independent chromatin immunoprecipitation assays. These genes code for regulators of Rho-GTPases, cell-cell and cell-matrix adhesion proteins, cytoskeleton-associated proteins, and markers of epithelial-to-mesenchymal transition. Interestingly, p110 CUX1 activated the expression of genes that promote cell motility and at the same time repressed genes that inhibit this process. Therefore, the role of p110 CUX1 in cell motility involves its functions in both activation and repression of transcription. This was best exemplified in the regulation of the E-cadherin gene. Indeed, we uncovered a regulatory cascade whereby p110 CUX1 binds to the snail and slug gene promoters, activates their expression, and then cooperates with these transcription factors in the repression of the E-cadherin gene, thereby causing disorganization of cell-cell junctions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19635798      PMCID: PMC2785698          DOI: 10.1074/jbc.M109.031849

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  WNT5A--target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancer.

Authors:  S Ripka; A König; M Buchholz; M Wagner; B Sipos; G Klöppel; J Downward; Tm Gress; P Michl
Journal:  Carcinogenesis       Date:  2007-01-16       Impact factor: 4.944

Review 2.  New signals from the invasive front.

Authors:  Gerhard Christofori
Journal:  Nature       Date:  2006-05-25       Impact factor: 49.962

Review 3.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

Authors:  Héctor Peinado; David Olmeda; Amparo Cano
Journal:  Nat Rev Cancer       Date:  2007-05-17       Impact factor: 60.716

4.  CUTL1 is phosphorylated by protein kinase A, modulating its effects on cell proliferation and motility.

Authors:  Patrick Michl; Beate Knobel; Julian Downward
Journal:  J Biol Chem       Date:  2006-03-30       Impact factor: 5.157

5.  Increased expression and activity of nuclear cathepsin L in cancer cells suggests a novel mechanism of cell transformation.

Authors:  Brigitte Goulet; Laurent Sansregret; Lam Leduy; Matthew Bogyo; Ekkehard Weber; Shyam S Chauhan; Alain Nepveu
Journal:  Mol Cancer Res       Date:  2007-09       Impact factor: 5.852

6.  Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesenchyme transition.

Authors:  S Julien; I Puig; E Caretti; J Bonaventure; L Nelles; F van Roy; C Dargemont; A Garcia de Herreros; A Bellacosa; L Larue
Journal:  Oncogene       Date:  2007-06-11       Impact factor: 9.867

7.  CUTL1 promotes tumor cell migration by decreasing proteasome-mediated Src degradation.

Authors:  T Aleksic; M Bechtel; D Krndija; G von Wichert; B Knobel; K Giehl; T M Gress; P Michl
Journal:  Oncogene       Date:  2007-03-19       Impact factor: 9.867

8.  Carboxyl-terminal proteolytic processing of CUX1 by a caspase enables transcriptional activation in proliferating cells.

Authors:  Mary Truscott; Jean-Bernard Denault; Brigitte Goulet; Lam Leduy; Guy S Salvesen; Alain Nepveu
Journal:  J Biol Chem       Date:  2007-08-06       Impact factor: 5.157

Review 9.  The multiple roles of CUX1: insights from mouse models and cell-based assays.

Authors:  Laurent Sansregret; Alain Nepveu
Journal:  Gene       Date:  2008-02-02       Impact factor: 3.688

10.  Genome-wide location analysis and expression studies reveal a role for p110 CUX1 in the activation of DNA replication genes.

Authors:  Ryoko Harada; Charles Vadnais; Laurent Sansregret; Lam Leduy; Ginette Bérubé; François Robert; Alain Nepveu
Journal:  Nucleic Acids Res       Date:  2007-11-14       Impact factor: 16.971

View more
  28 in total

Review 1.  Cathepsin L targeting in cancer treatment.

Authors:  Dhivya R Sudhan; Dietmar W Siemann
Journal:  Pharmacol Ther       Date:  2015-08-20       Impact factor: 12.310

Review 2.  The highs and lows of cannabinoid receptor expression in disease: mechanisms and their therapeutic implications.

Authors:  Lydia K Miller; Lakshmi A Devi
Journal:  Pharmacol Rev       Date:  2011-07-13       Impact factor: 25.468

3.  CUX1 modulates polarization of tumor-associated macrophages by antagonizing NF-κB signaling.

Authors:  B Kühnemuth; L Mühlberg; M Schipper; H Griesmann; A Neesse; N Milosevic; T Wissniowski; M Buchholz; T M Gress; P Michl
Journal:  Oncogene       Date:  2013-12-16       Impact factor: 9.867

4.  Glutamate receptor GRIA3--target of CUX1 and mediator of tumor progression in pancreatic cancer.

Authors:  Stefanie Ripka; Jan Riedel; Albrecht Neesse; Heidi Griesmann; Malte Buchholz; Volker Ellenrieder; Franz Moeller; Peter Barth; Thomas M Gress; Patrick Michl
Journal:  Neoplasia       Date:  2010-08       Impact factor: 5.715

5.  Snail transcription factor NLS and importin β1 regulate the subcellular localization of Cathepsin L and Cux1.

Authors:  Liza J Burton; Veronica Henderson; Latiffa Liburd; Valerie A Odero-Marah
Journal:  Biochem Biophys Res Commun       Date:  2017-07-08       Impact factor: 3.575

6.  Cathepsin L upregulation-induced EMT phenotype is associated with the acquisition of cisplatin or paclitaxel resistance in A549 cells.

Authors:  Mei-Ling Han; Yi-Fan Zhao; Cai-Hong Tan; Ya-Jie Xiong; Wen-Juan Wang; Feng Wu; Yao Fei; Long Wang; Zhong-Qin Liang
Journal:  Acta Pharmacol Sin       Date:  2016-11-14       Impact factor: 6.150

7.  MicroRNA122 is a key regulator of α-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma.

Authors:  Kentaro Kojima; Akemi Takata; Charles Vadnais; Motoyuki Otsuka; Takeshi Yoshikawa; Masao Akanuma; Yuji Kondo; Young Jun Kang; Takahiro Kishikawa; Naoya Kato; Zhifang Xie; Weiping J Zhang; Haruhiko Yoshida; Masao Omata; Alain Nepveu; Kazuhiko Koike
Journal:  Nat Commun       Date:  2011-06-07       Impact factor: 14.919

8.  Asynchronous expression of the homeodomain protein CUX1 in Sertoli cells and spermatids during spermatogenesis in mice.

Authors:  Melissa R Kroll; Engela S Viss; Jonathan Lamb; Joy Horstman; Alexander Powell; Andrea Van Wyk; Kaarlo Hinkkala; Traci Hoogland; Matthew Schippers; Stephen Shannon; Carol G Carlton; Madhulika Sharma; Aaron Taylor; Gregory B Vanden Heuvel; Tony N Jelsma
Journal:  Biol Reprod       Date:  2010-10-27       Impact factor: 4.285

9.  The roles of CUX1 homeodomain proteins in the establishment of a transcriptional program required for cell migration and invasion.

Authors:  Valérie Kedinger; Alain Nepveu
Journal:  Cell Adh Migr       Date:  2010-07-04       Impact factor: 3.405

10.  Upregulated Expression of CUX1 Correlates with Poor Prognosis in Glioma Patients: a Bioinformatic Analysis.

Authors:  Xiujie Wu; Fan Feng; Chuanchao Yang; Moxuan Zhang; Yanhao Cheng; Yayun Zhao; Yayu Wang; Fengyuan Che; Jian Zhang; Xueyuan Heng
Journal:  J Mol Neurosci       Date:  2019-08-03       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.